( such a force multiplier that venture in...)Proceeding with caution at corner of IT & biotech

such a force multiplier that venture investors can't resist it?

Hardly.

While scientists approach their value proposition from a technology standpoint, investors have a market perspective.

Mason Wells' support of OpGen has little to do with its IT component. D'Souza said the fact that OpGen has "a lot of IT" was neither a reason to do the deal, nor a reason not to do the......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 10/18/06


Page: 1 2 3 4
Related biology technology :

1. Sonic closer to turning profit corner
2. The state of global biotech: An Ernst & Young perspective
3. Olympics of biotechnology has international flavor
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Manufacturing partnership will move into biotech and biomedical spaces
8. Wisconsin wont get Georgia biotech without a fight
9. The 10 biggest events shaping biotech in 2006
10. NimbleGen partners with UK biotech firm
11. 2006: A great biotech financing year, unless you were going public!